Sign in

CIK 0000908259

  • Non-accelerated filer
  • Smaller reporting company

Oncotelic Therapeutics, Inc.

Sign in to watch
Ticker
OTLC
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
133679168
Phone
+1 650-635-7000
Business address
29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
Former names
MATEON THERAPEUTICS INC, OXIGENE INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market buy Director bought 5,000 shares at an average $4.69 ($23,426)
  9. 4 Open-market buy Director bought 6,000 shares at $4.67 ($28,020)
  10. 4 Open-market buy Director bought 5,000 shares at an average $4.39 ($21,935)
  11. 4 Open-market buy Chief Scientific Officer bought 2,000 shares at an average $7.46 ($14,912)
  12. 4/A Open-market buy President and CEO bought 2,000 shares at $7.31 ($14,620)
  13. 4 Grant or award President and CEO acquired 2,000 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 5 Insider Annual Insider Trading Report
  17. 5 Insider Annual Insider Trading Report
  18. 5 Insider Annual Insider Trading Report
  19. 4/A Derivatives Options or other derivatives
  20. 4/A Derivatives Options or other derivatives

Page 14 of 17 · 325 filings